HRES 753 — Recognizing that the occurrence of prostate cancer in African-American men has reached epidemic proportions and urging Federal agencies to address that health crisis by supporting education, awareness outreach, and research specifically focused on how prostate cancer affects African-American men.

1 sponsors · 0 co-sponsors · 546 not signed on

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Frequently asked questions

What does HRES 753 do?

Recognizes: (1) that prostate cancer has created a health crisis for African-American men; and (2) the importance of health coverage and access to care, as well as promoting informed decisionmaking between men and their doctors, taking into consideration the known risks and potential benefits of screening and treatment options for prostate cancer. Urges federal agencies to support: (1) research to address and attempt to end that crisis; (2) efforts relating to education, awareness, and early detection at the grassroots level; and (3) the Office of Minority Health of the Department of Health and Human Services (HHS) in focusing on improving health and health care outcomes for African Americans at an elevated risk. Urges investment by federal agencies in research focusing on the improvement of early detection and treatment, such as the use of: (1) biomarkers to distinguish indolent forms of prostate cancer from lethal forms, and (2) advanced imaging tools.

Who sponsors HRES 753?

HRES 753 is sponsored by Gregory Meeks (D).

What is the current status of HRES 753?

This bill died with 112th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

Where can I track HRES 753?

Track HRES 753 free on One Click Politics — get push/email alerts when it moves.